Nov, 22: Pfizer Inc (PFE.N) announced on Monday that, its COVID-19 vaccine showed strong long-term protection against the virus in a late-stage study performed among adolescents aged 12 to 15 years. Pfizer and BioNTech will seek approval for a 30 micrograms dose of the vaccine for those aged 12 and above.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Israeli air force intercepts projectile from central Gaza

The Israeli army said it has intercepted a projectile that crossed into…

Mass Israel protests after Netanyahu fires minister

Tens of thousands of people have taken to the streets across Israel…

‘No imminent deal with KSA and Indonesia’: Israeli FM

Jerusalem: On Jan 25, Israel’s top diplomat said that it hoped to…

Pakistan reports less than 1000 Covid-19 cases for the second consecutive day

For the second day in a row, Pakistan reported fewer than 1,000…